Skip to main content
FinSpry Logo
FinSpry
VCYT logo
VCYT
(NASDAQ)
Veracyte, Inc.
$53.19-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Veracyte (VCYT) Stock Price & Financial Analysis

Veracyte Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$51.92 - $53.81
52-Week High$53.81
52-Week Low$22.61
Open$51.96
Volume4.13M
Average Volume (3M)1.30M
Market Cap4.36B
Shares Outstanding81.31M
P/E Ratio (TTM)49.55
Forward P/E24.43
Price to Sales (P/S)8.05
Price to Book (P/B)3.24
EV/EBITDA36.86
Revenue (TTM)541.74M
Net Income (TTM)88.01M
Free Cash Flow (TTM)154.81M
EPS (TTM)$1.10
Profit Margin16.25%
Operating Margin18.68%
Return on Equity (ROE)6.55%
Debt to Equity0.03
50-Day MA$40.73
200-Day MA$38.43
52-Week Change99.96%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Veracyte

What is the current stock price for VCYT?

As of the latest trading session, VCYT stock trades at $53.63. The 52-week range is $22.61–$53.81, with a day range of $51.92–$53.81.

What is the P/E ratio for VCYT?

Veracyte's trailing P/E ratio is 49.5, meaning investors pay $49.5 for every $1 of annual earnings. The forward P/E is 24.4, reflecting analyst expectations for future earnings. Veracyte operates in the Healthcare sector.

Does VCYT pay dividends?

Veracyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VCYT?

Based on 11 analysts, the consensus for VCYT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VCYT?

Veracyte's market capitalization is $4.36B, classifying it as a mid-cap company. Veracyte operates in the Healthcare sector within the Diagnostics & Research industry.